引用次数
引用: 14,318
H-指数: 63
I10-指数 : 131
出版物: 320
Development of a two-site ELISA assay for the dimeric form of human TFF1.
M Pu , F.E.B May , R.J Playford , M.-H Ruchaud-Sparagano
Peptides 25 ( 5) 731 -736
4
2004
Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis.
A.J FitzGerald , M Pu , T Marchbank , B.R Westley
Peptides 25 ( 5) 793 -801
37
2004
Luminal Growth Factors and Intestinal Growth
A.P Jenkins , R.P.H Thompson , M.E Murray , A Grundy
The Lancet 341 ( 8854) 1212 -1213
2
1993
Does the response of the intestinal epithelium to keratinocyte growth factor vary according to the method of administration
R.A Goodlad , N Mandir , K Meeran , M.A Ghatei
Regulatory Peptides 87 ( 1) 83 -90
16
2000
Effects of pathophysiological concentrations of peptide YY on the human kidney
R.J Playford , S Mehta , M Zaffer , M Ghatei
Regulatory Peptides 47 ( 1) 108
1993
Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice.
O. BASHIR , A. J. FITZGERALD , J. BERLANGA-ACOSTA , R. J. PLAYFORD
Clinical Science 105 ( 3) 323 -330
22
2003
Effects of diet and the cholecystokinin antagonist; devazepide (L364,718) on CCK mRNA, and tissue and plasma CCK concentrations.
R. J. PLAYFORD , A. W. KING , P. H. DEPREZ , J. DE-BELLEROCHE
European Journal of Clinical Investigation 23 ( 10) 641 -647
4
1993
Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury
T. MARCHBANK , J. K. LIMDI , A. MAHMOOD , G. ELIA
Alimentary Pharmacology & Therapeutics 28 ( 6) 799 -804
64
2008
Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure
Danay Cibrián , Hussam Ajamieh , Jorge Berlanga , Olga S. León
Clinical Science 110 ( 5) 563 -573
23
2006
Synergistic enhancement of Toll-like receptor responses by NOD1 activation.
David A. van Heel , Subrata Ghosh , Matt Butler , Karen Hunt
European Journal of Immunology 35 ( 8) 2471 -2476
140
2005
Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
David A. van Heel , Karen A. Hunt , Subrata Ghosh , Mireille Hervé
European Journal of Immunology 36 ( 6) 1629 -1635
12
2006
Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium.
Matt Butler , Chi-Yan Ng , David A. van Heel , Giovanna Lombardi
European Journal of Immunology 36 ( 4) 864 -874
70
2006
Peptide therapy and the gastroenterologist: colostrum and milk-derived growth factors
R PLAYFORD
Clinical Nutrition 20 101 -106
18
2001
Consideration of histopathological subtypes and biopsy techniques in Barrett’s oesophagus surveillance programmes
R FITZGERALD , W BURNHAM , C MACDONALD , A WICKS
Gut 42 ( 3) 448.2 -448
1998
THE STOMACH AND DUODENUM OF PATIENTS WITH ARTHRITIS RESPOND TO NONSTEROID ANTIINFLAMMATORY DRUG ADMINISTRATION BY INCREASING CELL TURNOVER
S LEVI , RA GOODLAD , G STAMP , C LEE
GUT 31 ( 5) A599 -A600
1990
A dose escalating, placebo controlled, double blind, dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon γ antibody, in patients with moderate to severe Crohn's disease. Commentary
S GHOSH , R CHOUDHORY , M CARPANI , R PLAYFORD
Gut 55 ( 8)
2006
BASIC–ALIMENTARY TRACT
ADRIAAN A VAN BODEGRAVEN , CHRISTINE R CURLEY , KAREN A HUNT , ALIENKE J MONSUUR
GASTROENTEROLOGY 131 1768 -1774
2006
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Commentary
S GHOSH , R CHAUDHARY , M CARPANI , RJ PLAYFORD
Gut 55 ( 1) 6 -8
2006
Peptide gene expression in gastrointestinal mucosal
WM WONG , RJ PLAYFORD , NA WRIGHT
IMPORTANCE OF CHOLECYSTOKININ (CCK) SYNTHESIS IN RESPONSE TO RAW SOYA AND THE CCK-ANTAGONIST, DEVAZEPIDE
RJ PLAYFORD , C BEARDSHALL , J DEBELLEROCHE , AW KING
GUT 31 ( 5) A620 -A620
1990